Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Cancer GeneticsOpGenCBA FloridaAvant DiagnosticsFirst Choice Healthcare Solutions
SymbolNASDAQ:CGIXNASDAQ:OPGNOTCMKTS:CBAIOTCMKTS:AVDXOTCMKTS:FCHS
Price Information
Current Price$4.53$1.63$0.01$0.03$0.16
52 Week RangeN/ABuyN/AN/AN/A
Analyst Ratings
Consensus RecommendationN/ABuyN/AN/AN/A
Consensus Price TargetN/A$7.93N/AN/AN/A
% Upside from Price TargetN/A386.71% upsideN/AN/AN/A
Trade Information
Market Cap$9.51 million$9.13 million$10.56 million$10.78 million$5.27 million
Beta2.540.55-0.289.420.71
Average Volume53,7291,501,3873,647,3054,9369,545
Sales & Book Value
Annual Revenue$27.47 million$2.95 millionN/A$250,000.00$28.74 million
Price / Sales0.353.09N/A43.130.18
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$7.37 per share$7.66 per share$0.01 per share$0.01 per shareN/A
Price / Book0.610.21N/A3.20
Profitability
Net Income$-20,370,000.00$-13,370,000.00$13.17 million$-2,370,000.00$-3,880,000.00
EPSN/A($44.40)N/AN/AN/A
Trailing P/E RatioN/AN/A0.000.000.00
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-59.28%-397.44%N/AN/AN/A
Return on Equity (ROE)-139.59%-662.90%-14.89%-143.01%N/A
Return on Assets (ROA)-28.46%-144.19%-14.01%-51.41%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.02%1.07%N/AN/AN/A
Current Ratio0.99%0.31%19.24%0.02%N/A
Quick Ratio0.99%0.24%19.24%0.02%N/A
Ownership Information
Institutional Ownership PercentageN/A1.29%N/A0.03%N/A
Insider Ownership Percentage15.00%4.96%30.00%38.01%30.81%
Miscellaneous
Employees1504422207
Shares Outstanding2.10 million5.60 million1.27 billion336.96 million32.96 million
Next Earnings Date4/21/2020 (Estimated)2/25/2020 (Estimated)N/AN/AN/A
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel